Ghisallo Capital Management’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

Ghisallo Capital Management’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-224,913	Closed	-$2.24M	–	137
2022 Q4	$2.24M	Sell	224,913 -400	-0.2%	-$3.94K	0.4%	57
2022 Q3	$2.19M	Hold	225,313	–	–	0.29%	130
2022 Q2	$2.18M	Hold	225,313	–	–	0.27%	136
2022 Q1	$2.2M	Hold	225,313	–	–	0.24%	158
2021 Q4	$2.21M	Hold	225,313	–	–	0.11%	260
2021 Q3	$2.21M	Buy	+225,313	New	+$2.23M	0.08%	270

Other funds holding DALS

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ghisallo Capital Management's DALS Position: Q1 2023 in Review

Ghisallo Capital Management sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q1 2023, closing a stake of 224,913 shares — an estimated $2.24M sold.

Ghisallo Capital Management first reported a position in DALS in Q3 2021 and held it in 6 quarters. The position peaked at $2.24M in Q4 2022. 50 funds tracked by Wall St. Rank hold DALS as of Q1 2023.

Ghisallo Capital Management reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Ghisallo Capital Management sold 224,913 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $2.24M.
Ghisallo Capital Management first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 6 quarters.
Ghisallo Capital Management's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $2.24M in Q4 2022.
50 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Ghisallo Capital Management's 13F filing for Q1 2023, filed 15 May 2023.